Preliminary research point out conolidine could inhibit particular ion channels, lessening neuronal excitability and restricting soreness signals. This mechanism is particularly related in neuropathic suffering, where by abnormal signaling will cause persistent distress. Furthermore, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to suffering notion. ... https://joana269qub1.wikigdia.com/user